MedPath

Comparative Effect Of Conventional and New Antiepileptic Drug Therapy On Serum Thyroid Profile In Adult Epileptic Patients

Not Applicable
Completed
Conditions
Health Condition 1: null- EPILEPSY PATIENTS and HEALTHY VOLUNTEERS
Registration Number
CTRI/2017/12/010809
Lead Sponsor
Self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
56
Inclusion Criteria

1 Patients aged between 18-60 years of age of either gender with epilepsy who are on stable dose of single antiepileptic drug for at least 6 months

2 Patients willing to give written informed consent

Exclusion Criteria

1 Patients on combination therapy with antiepileptic drugs

2 Patients who are noncompliant to the drug

3 Patients with history of progressive or psychiatric neurological disorder

4 Patients with refractory seizures

5 Patients who are on anti thyroid drugs or on thyroid hormone replacement therapy

6 Patients with other co morbid conditions like ischemic heart disease, stroke, chronic kidney disease, liver disease, diabetes mellitus, and hypertension and other metabolic diseases

7 Patients who had received the drugs, which could affect the level of thyroid hormones, in the past 6 months

8 pregnant and lactating mothers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of Serum triiodothyronine (T3), thyroxine (T4) and thyroid stimulating hormone (TSH)Timepoint: cross sectional study
Secondary Outcome Measures
NameTimeMethod
Measurement of Serum triiodothyronine (T3), thyroxine (T4) and thyroid stimulating hormone (TSH)Timepoint: cross sectional study
© Copyright 2025. All Rights Reserved by MedPath